Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Environmental Transmission Electron Microscope

By Drug Discovery Trends Editor | May 8, 2009

FEI TitanFEI Company received the 100th order for its Titan microscope. Stanford University has ordered the Titan 80-300 environmental transmission electron microscope (ETEM) for a new facility associated with its Nanocharacterization Laboratory. The Titan ETEM is designed for chemical and catalyst research at the atomic scale, and provides unique capabilities for studying dynamic processes of materials under gas and elevated temperature conditions. The multi-million dollar system will ship to Stanford University in the first half of 2010.

The University will be using the Titan ETEM to explore the synthesis and understanding of new materials for energy and the environment, and to study the responses of different materials as a function of temperature and gas type down to the atomic level. The Titan ETEM at Stanford will also be equipped with a spherical aberration image corrector and a monochromator, permitting direct viewing and analysis of interactions between the sample and its environment at the atomic scale.

The Titan ETEM’s ability to observe the sample in a controlled gaseous state is important in applications with the aim of studying interactions between various materials and their environment. This includes processes such as corrosion, oxidation, and catalysis for new materials and energy.

FEI Company 


Filed Under: Drug Discovery

 

Related Articles Read More >

Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
First clinical study results of Dupixent for atopic dermatitis in patients with darker skin tones 
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE